256 related articles for article (PubMed ID: 23040068)
21. Activation of G protein-coupled bile acid receptor, TGR5, induces smooth muscle relaxation via both Epac- and PKA-mediated inhibition of RhoA/Rho kinase pathway.
Rajagopal S; Kumar DP; Mahavadi S; Bhattacharya S; Zhou R; Corvera CU; Bunnett NW; Grider JR; Murthy KS
Am J Physiol Gastrointest Liver Physiol; 2013 Mar; 304(5):G527-35. PubMed ID: 23275618
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator activated receptor-γ-Rho-kinase interactions contribute to vascular remodeling after chronic intrauterine pulmonary hypertension.
Gien J; Tseng N; Seedorf G; Roe G; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2014 Feb; 306(3):L299-308. PubMed ID: 24375792
[TBL] [Abstract][Full Text] [Related]
23. Activation of G protein-coupled estrogen receptor 1 induces coronary artery relaxation via Epac/Rap1-mediated inhibition of RhoA/Rho kinase pathway in parallel with PKA.
Yu X; Zhang Q; Zhao Y; Schwarz BJ; Stallone JN; Heaps CL; Han G
PLoS One; 2017; 12(3):e0173085. PubMed ID: 28278256
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin II induces RhoA activation through SHP2-dependent dephosphorylation of the RhoGAP p190A in vascular smooth muscle cells.
Bregeon J; Loirand G; Pacaud P; Rolli-Derkinderen M
Am J Physiol Cell Physiol; 2009 Nov; 297(5):C1062-70. PubMed ID: 19692654
[TBL] [Abstract][Full Text] [Related]
25. RhoA/ROCK Pathway Activation is Regulated by AT1 Receptor and Participates in Smooth Muscle Migration and Dedifferentiation via Promoting Actin Cytoskeleton Polymerization.
Qi Y; Liang X; Dai F; Guan H; Sun J; Yao W
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751352
[TBL] [Abstract][Full Text] [Related]
26. Hypertension-Causing Mutation in Peroxisome Proliferator-Activated Receptor γ Impairs Nuclear Export of Nuclear Factor-κB p65 in Vascular Smooth Muscle.
Mukohda M; Lu KT; Guo DF; Wu J; Keen HL; Liu X; Ketsawatsomkron P; Stump M; Rahmouni K; Quelle FW; Sigmund CD
Hypertension; 2017 Jul; 70(1):174-182. PubMed ID: 28507170
[TBL] [Abstract][Full Text] [Related]
27. Rho kinase and hypertension.
Wirth A
Biochim Biophys Acta; 2010 Dec; 1802(12):1276-84. PubMed ID: 20460153
[TBL] [Abstract][Full Text] [Related]
28. RhoA and Rho kinase activation in human pulmonary hypertension: role of 5-HT signaling.
Guilluy C; Eddahibi S; Agard C; Guignabert C; Izikki M; Tu L; Savale L; Humbert M; Fadel E; Adnot S; Loirand G; Pacaud P
Am J Respir Crit Care Med; 2009 Jun; 179(12):1151-8. PubMed ID: 19299501
[TBL] [Abstract][Full Text] [Related]
29. Atorvastatin inhibits myocardin expression in vascular smooth muscle cells.
Li J; Jiang J; Yin H; Wang L; Tian R; Li H; Wang Z; Li D; Wang Y; Gui Y; Walsh MP; Zheng XL
Hypertension; 2012 Jul; 60(1):145-53. PubMed ID: 22615115
[TBL] [Abstract][Full Text] [Related]
30. Cullin 3 regulates ADAMs-mediated ectodomain shedding of amphiregulin.
Nakayama H; Sakaue T; Maekawa M; Fujisaki A; Higashiyama S
Biochem Biophys Res Commun; 2018 Apr; 499(1):17-23. PubMed ID: 29550478
[TBL] [Abstract][Full Text] [Related]
31. Smooth muscle specific Rac1 deficiency induces hypertension by preventing p116RIP3-dependent RhoA inhibition.
André G; Sandoval JE; Retailleau K; Loufrani L; Toumaniantz G; Offermanns S; Rolli-Derkinderen M; Loirand G; Sauzeau V
J Am Heart Assoc; 2014 Jun; 3(3):e000852. PubMed ID: 24938713
[TBL] [Abstract][Full Text] [Related]
32. Heparin inhibits pulmonary artery smooth muscle cell proliferation through guanine nucleotide exchange factor-H1/RhoA/Rho kinase/p27.
Yu L; Quinn DA; Garg HG; Hales CA
Am J Respir Cell Mol Biol; 2011 Apr; 44(4):524-30. PubMed ID: 20558775
[TBL] [Abstract][Full Text] [Related]
33. RhoA/Rho kinase (ROCK) alters fetuin-A uptake and regulates calcification in bovine vascular smooth muscle cells (BVSMC).
Chen NX; Chen X; O'Neill KD; Atkinson SJ; Moe SM
Am J Physiol Renal Physiol; 2010 Sep; 299(3):F674-80. PubMed ID: 20610533
[TBL] [Abstract][Full Text] [Related]
34. Smooth Muscle-Targeted Overexpression of Peroxisome Proliferator Activated Receptor-γ Disrupts Vascular Wall Structure and Function.
Kleinhenz JM; Murphy TC; Pokutta-Paskaleva AP; Gleason RL; Lyle AN; Taylor WR; Blount MA; Cheng J; Yang Q; Sutliff RL; Hart CM
PLoS One; 2015; 10(10):e0139756. PubMed ID: 26451838
[TBL] [Abstract][Full Text] [Related]
35. A novel RhoA/ROCK-CPI-17-MEF2C signaling pathway regulates vascular smooth muscle cell gene expression.
Pagiatakis C; Gordon JW; Ehyai S; McDermott JC
J Biol Chem; 2012 Mar; 287(11):8361-70. PubMed ID: 22275376
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin II Silencing Alleviates Erectile Dysfunction Through Down-Regulating the Rhoa/Rho Kinase Signaling Pathway in Rats with Diabetes Mellitus.
Zhang Y; Jia L; Zhang Y; Ji W; Li H
Cell Physiol Biochem; 2018; 45(1):419-427. PubMed ID: 29402797
[TBL] [Abstract][Full Text] [Related]
37. Peroxisome proliferator-activated receptor-γ mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system.
Auclair M; Vigouroux C; Boccara F; Capel E; Vigeral C; Guerci B; Lascols O; Capeau J; Caron-Debarle M
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):829-38. PubMed ID: 23393388
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of RhoA/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1α-dependent functional TRPC channels.
Wang XY; Mo D; Tian W; Liu XX; Zhou YG; Sun Y; Feng YD; Xiao X; Hao XW; Zhang HN; Li C; Cao W; Li XQ
Toxicol Appl Pharmacol; 2019 Apr; 369():60-72. PubMed ID: 30831131
[TBL] [Abstract][Full Text] [Related]
39. A molecular mechanism for ibuprofen-mediated RhoA inhibition in neurons.
Dill J; Patel AR; Yang XL; Bachoo R; Powell CM; Li S
J Neurosci; 2010 Jan; 30(3):963-72. PubMed ID: 20089905
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of RhoA/Rho kinase pathway and smooth muscle contraction by hydrogen sulfide.
Nalli AD; Wang H; Bhattacharya S; Blakeney BA; Murthy KS
Pharmacol Res Perspect; 2017 Oct; 5(5):. PubMed ID: 28971603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
